[1]袁超,陶健,袁媛,等.血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2009,33(6):353-355.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
 YUAN Chao,TAO Jian,YUAN Yuan,et al.The diagnostic significance of CA15-3, CEA combined with whole body bone scan for bone metastases in patients with breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):353-355.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
点击复制

血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第6期
页码:
353-355
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The diagnostic significance of CA15-3, CEA combined with whole body bone scan for bone metastases in patients with breast cancer
作者:
袁超 陶健 袁媛 孙伟莉
蚌埠医学院第一附属医院核医学科, 蚌埠 233004
Author(s):
YUAN Chao TAO Jian YUAN Yuan SUN Wei-li
Department of Nuclear Medicine, the First Affiliated Hospital of Bengbu Medical College, Anhui Bengbu 233004, China
关键词:
乳腺肿瘤肿瘤转移全身成像99m锝美罗酸盐抗原肿瘤相关碳水化合物癌胚抗原
Keywords:
Breast neoplasmsNeoplasm metastasiswhole body imagingTechnetium Tc 99m medronateAntigenstumor-associatedcarbohydrateCarcinoembryonic antigen
DOI:
10.3760/cma.j.issn.1673-4114.2009.06.011
摘要:
目的 探讨血清糖类抗原15-3(carbonhydrate antigen 15-3,CA15-3)、癌胚抗原(carcinoembryonic antigen,CEA)测定联合全身骨显像(WBS)对提高乳腺癌骨转移诊断的临床价值。方法 对92例乳腺癌患者分别进行血清CA15-3、CEA检测和WBS,并进行对比分析。结果 乳腺癌骨转移组,血清CA15-3和CEA水平显着增高,与无骨转移的乳腺癌组比较有统计学差异(CA15.3:t=91.8342;CEA:t=77.6323,P<0.01)。CA15-3、CEA及全身骨显像联合检测对诊断乳腺癌骨转移其灵敏度、特异度分别为95.74%、88.89%,较单独检测某项指标诊断效率均有提高。结论 血清CA15-3、CEA及全身骨显像联合检测可提高乳腺癌骨转移的诊断效率,特别是全身骨显像结果模棱两可时意义更大。
Abstract:
Objective To investigate the diagnostic significance of carbonhydrate anitigen 15-3,(CAl5-3), carcinoembryonic antigen(CEA) combined with whole body bone scan(WBS) for bone metastases in patients with breast cancer. Methods Serum levels of CA153 and CEA were measured and WBS was performed in 92 breast cancer patients. Results Serum levels of CA153 and CEA were higher in bone metastases group than in without bone metastases group significantly(CA15.3:t=91.8342; CEA:t=77.6323,P<0.01). The sensitivity and specificity of combined determinations of CA153, CEA and WBS were 95.74% and 88.89% respectively, its diagnostic efficiency was higher than any one of them. Conclusion The combined detection of CA153, CEA and WBS can improve the diagnostic efficiency of bone metastases in patient with breast cancer, especially when the results of bone scanning is equivocal.

参考文献/References:

[1] Araujo J,Logothetis C.Targeting Src signaling in metastatic bone disease.Int J Cancer,2009,124(1):1-6.
[2] Wojtacki J,Kruszewski WJ,Sliwińska M,et al.Elevation of serum Ca 15-3 antigen:an early indicator of distant metastasis from breast cancer.Retrospective analysis of 733 cases.Przegl Lek,2001,58(6):498-503.
[3] 陆云飞,向俾庭,曾健,等.血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值.广西医科大学学报,2006,23(2):173-175.
[4] Tubiana-Hulin M.Incidence,prevalence and distribution of bone metastasis.Bone,1991,12(suppl 1):S9-S10.
[5] Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.J Clin Oncol,2007,25(33):5287-5312.
[6] Nicolini A,Carpi A,Ferrari P,et al.Utility of a serum tumourmarker pane] in the post-operative follow-up of breast cancerpatients with equivocal conventional radiological examinations.Tumour Biol,2003,24(6):275-280.
[7] Zissimopoulos A,Petrakis G,Stellos K,et al.Procollagen-I,collagen telopeptide I,CEA,CA15-3 as compared to bone scintigraphy in patients with breast cancer-Hell J Nucl Med,2006,9(1):60-64.

相似文献/References:

[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
 Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
 Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
 chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
 Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[5]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
 Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[6]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
 Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[7]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
 Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[8]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
 Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[9]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
 Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[10]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
 Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[11]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
 Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[12]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
 Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[13]樊孝廉,鲁胜男,古炎发,等.乳腺癌患者骨病灶SPECT/CT融合显像的临床价值[J].国际放射医学核医学杂志,2013,37(4):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
 FAN Xiao-lian,LU Sheng-nan,GU Yan-fa,et al.The clinical value of SPECT/CT fusion imaging in the diagnosis of bone metastasis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
[14]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
 YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[15]路宝士,高玉芳.血清CA15-3、CEA检测联合全身骨显像在乳腺癌骨转移中的诊断价值[J].国际放射医学核医学杂志,2011,35(2):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
 LU Bao-shi,GAO Yu-fang.The value of combined examination of serum CA15-3, CEA level and whole body bone scan in the diagnosis of bone metastasis in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
[16]佟丽娟,王明泽,王丽梅.肺癌、乳腺癌、食道癌远端骨转移特点的对比研究[J].国际放射医学核医学杂志,2011,35(1):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
 TONG Li-juan,WANG Ming-ze,WANG Li-mei.Comparative study between characteristics of the lung cancer, breast cancer and esophageal cancer distal bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
[17]张亶,章斌,邓胜明,等.18F-FDG PET/CT在乳腺癌术后随访中的价值[J].国际放射医学核医学杂志,2017,41(3):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
 Zhang Dan,Zhang Bin,Deng Shengming,et al.Clinical value of 18F-FDG PET/CT in follow-up of postoperative breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(6):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
[18]张雪辉,杨贵生,肖国有.乳腺癌骨转移的影像学诊断进展[J].国际放射医学核医学杂志,2017,41(4):278.[doi:10.3760/cma.j.issn.1673-4114.2017.04.008]
 Zhang Xuehui,Yang Guisheng,Xiao Guoyou.Imaging for diagnosis of bone metastases in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(6):278.[doi:10.3760/cma.j.issn.1673-4114.2017.04.008]

备注/Memo

备注/Memo:
收稿日期:2009-07-20。
通讯作者:袁超(E-mail:ychsysu@yahoo.com.cn)
更新日期/Last Update: 1900-01-01